Mark E. Williams

Mark E. Williams, D. Chianchiano, 2002, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

The involuntarily discharged dialysis patient: conflict (of interest) with providers.

Mark E. Williams, J. Kitsen, 2005, Advances in chronic kidney disease.

Promise or peril? Impact of the Medicare drug benefit on the ESRD population.

Mark E. Williams, 2004, Advances in chronic kidney disease.

Diabetic CKD/ESRD 2010: A Progress Report?

Mark E. Williams, 2010, Seminars in dialysis.

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease

Mark E. Williams, 2004, Current diabetes reports.

A Controlled Clinical Trial of Angiotensin-Converting Enzyme Inhibition in Type I Diabetic Nephropathy: Study Design and Patient Characteristics

Mark E. Williams, J. Breyer, R. Bain, 1992 .

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

Mark E. Williams, J. Coburn, S. Sprague, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The UNOS 'preferential allocation' concept proposal for the allocation of deceased donor kidney transplants: implications for patients with diabetes.

Mark E. Williams, Anthony C Breu, Shuai Xu, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Mark E. Williams, P. Kimmel, A. Hung, 2019, Kidney international.

Chapter 64 – End-Stage Renal Failure in the Diabetic Patient

Mark E. Williams, 2017 .

New therapies for advanced glycation end product nephrotoxicity: current challenges.

Mark E. Williams, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Principles of separation: indications and therapeutic targets for plasma exchange.

Mark E. Williams, R. Balogun, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Combination Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD (HIDE): A Randomized, Placebo-Controlled, Pilot Trial.

Mark E. Williams, P. Kimmel, S. Waikar, 2020, Kidney360.

High Hemoglobin A1c levels and glycemic variability increase risk of severe hypoglycemia in diabetic hemodialysis patients

Mark E. Williams, R. Lacson, R. Garg, 2014, Hemodialysis international. International Symposium on Home Hemodialysis.

Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy

Mark E. Williams, P. Raskin, B. Freedman, 2004, American Journal of Nephrology.

Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.

Mark E. Williams, F. Epstein, S. Karumanchi, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The ESRD uninsured matter.

Mark E. Williams, 2007, Advances in chronic kidney disease.

Making sense of glucose sensors in end-stage kidney disease: A review

Mark E. Williams, Devin W. Steenkamp, H. Wolpert, 2022, Frontiers in Clinical Diabetes and Healthcare.

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Mark E. Williams, B. Shaz, R. Balogun, 2013, Journal of clinical apheresis.

Evaluation and care of elderly patients with dementia

Mark E. Williams, E. Larson, B. Lo, 1986, Journal of General Internal Medicine.

Chapter 10 – Management of the Diabetic End-Stage Renal Disease (ESRD) Patient: Dialysis and Transplantation

Mark E. Williams, K. Tuohy, 2005 .

Salsalate kinetics in patients with chronic renal failure undergoing hemodialysis

Mark E. Williams, M. Weinblatt, L. Harrison, 1986, Clinical pharmacology and therapeutics.

Impairment of Extrarenal Potassium Disposal by α-Adrenergic Stimulation

Mark E. Williams, F. Epstein, Robert S. Brown, 1984 .

Diabetic kidney disease in elderly individuals.

Mark E. Williams, 2013, The Medical clinics of North America.

Diabetic Nephropathy: The Proteinuria Hypothesis

Mark E. Williams, 2005, American Journal of Nephrology.

Same-Sex Partnerships and the Health of Lesbian, Gay and Bisexual Older Adults

Mark E. Williams, 2012 .

Diabetic kidney disease in the older adult: an update

Mark E. Williams, 2009 .

The Glycemic Indices in Dialysis Evaluation (GIDE) study: Comparative measures of glycemic control in diabetic dialysis patients

Mark E. Williams, E. Lacson, N. Mittman, 2015, Hemodialysis international. International Symposium on Home Hemodialysis.

Hemoglobin A1c in the ESRD Population: Status Report

Mark E. Williams, 2014, Seminars in dialysis.

Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses.

Mark E. Williams, R. Hakim, J. Lazarus, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Management of diabetes in dialysis patients

Mark E. Williams, 2009, Current diabetes reports.

Chapter 3 – Diabetic Kidney Disease: Current Challenges

Mark E. Williams, R. Stanton, 2010 .

A Quality Improvement Model for Optimizing Care of the Diabetic End‐Stage Renal Disease Patient

Mark E. Williams, R. Mahnensmith, Y. Hsu, 2010, Seminars in dialysis.

SAME-SEX PARTNERSHIPS AND THE HEALTH OF OLDER ADULTS.

Mark E. Williams, K. Fredriksen-Goldsen, 2014, Journal of Community Psychology.

Venous Thoracic Outlet Syndrome Simulating Subclavian Stenosis in a Hemodialysis Patient

Mark E. Williams, 1998, American Journal of Nephrology.

Glycemic management in ESRD and earlier stages of CKD.

Mark E. Williams, R. Garg, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Diabetes management in the kidney patient.

Mark E. Williams, R. Garg, 2013, The Medical clinics of North America.

Nutritional and Metabolic Management of Obesity and the Metabolic Syndrome in the Patient with Chronic Kidney Disease

Mark E. Williams, G. Blackburn, G. Magerowski, 2013 .

Nutritional and Metabolic Management of the Diabetic Patient with Chronic Kidney Disease and Chronic Renal Failure

Mark E. Williams, R. Stanton, 2013 .

Social Adaptability Index: application and outcomes in a dialysis population.

Mark E. Williams, S. Gautam, B. Baird, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Coronary revascularization in diabetic chronic kidney disease/end-stage renal disease: a nephrologist's perspective.

Mark E. Williams, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Illness as the focus of geriatric medicine.

Mark E. Williams, N. Hadler, 1983, The New England journal of medicine.

American society for apheresis guidelines support use of red cell exchange transfusion for severe malaria with high parasitemia.

Mark E. Williams, B. Shaz, R. Balogun, 2014, Clinical Infectious Diseases.

Reliability of a Modified Medication Appropriateness Index in Ambulatory Older Persons

Mark E. Williams, M E Williams, C. C. Pulliam, 1997, The Annals of pharmacotherapy.

Reducing Hospital Costs for the Geriatric Patient Admitted from the Emergency Department: A Randomized Trial

Mark E. Williams, J. Feinglass, B. Naughton, 1994, Journal of the American Geriatrics Society.

Quantifying the Ease or Difficulty Older Persons Experience in Opening Medication Containers

Mark E. Williams, Stevan Keram, Mark E. Williams, 1988, Journal of the American Geriatrics Society.

In Quality We Trust; but Quality of Life or Quality of Care?

Mark E. Williams, M. Unruh, S. Chen, 2016, Seminars in dialysis.

Identifying the Older Person Likely to Require Long‐Term Care Services

Mark E. Williams, 1987, Journal of the American Geriatrics Society.

Role of Functional Assessment in the Evaluation of Urinary Incontinence

Mark E. Williams, S. Gaylord, 1990, Journal of the American Geriatrics Society.

Controversy about COOPERATE ABPM Trial Data

Mark E. Williams, P. Vardas, F. Logerfo, 2006 .

Chronic Care Clinics: Why Don't They Work?

Mark E. Williams, M. E. Williams, 1999, Journal of the American Geriatrics Society.

Glutamate decarboxylase65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain

Mark E. Williams, F. Benes, M. Todtenkopf, 2000, Journal of Chemical Neuroanatomy.

New Potential Agents in Treating Diabetic Kidney Disease

Mark E. Williams, 2012, Drugs.

The Short‐Term Effect of Interdisciplinary Medication Review on Function and Cost in Ambulatory Elderly People

Mark E. Williams, C. C. Pulliam, Jeanne M. Kincaid, 2004, Journal of the American Geriatrics Society.

Timed Manual Performance In a Community Elderly Population

Mark E. Williams, W. McGaghie, S. Gaylord, 1990, Journal of the American Geriatrics Society.

Diagnosis and Treatment of Depression in Late Life

Mark E. Williams, W. H. Hall, B. Lebowitz, 1992 .

Clinical Geriatric Research

Mark E. Williams, Sheldon M. Retch, 1984, Journal of the American Geriatrics Society.

Management of the diabetic transplant recipient.

Mark E. Williams, M. E. Williams, 1995, Kidney international.

Caring for our future selves.

Mark E. Williams, Jonathan Evans, 2004, The American journal of medicine.

Protothecosis complicating prolonged endotracheal intubation: case report and literature review.

Mark E. Williams, M. Williams, P. Degirolami, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A quantitative method of identifying older persons at risk for increasing long term care services.

Mark E. Williams, J. C. Hornberger, 1984, Journal of chronic diseases.

Manual ability as a marker of dependency in geriatric women.

Mark E. Williams, M. E. Williams, N. Hadler, 1982, Journal of chronic diseases.

Fumonisin mycotoxicosis in broilers: performance and pathology.

Mark E. Williams, G. Rottinghaus, M. Williams, 1992, Avian diseases.

Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival.

Mark E. Williams, J. Lazarus, E. Lacson, 2006, Kidney international.

The Goal of Blood Pressure Control for Prevention of Early Diabetic Microvascular Complications

Mark E. Williams, 2011, Current diabetes reports.

Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation.

Mark E. Williams, P. Greenland, M. E. Williams, 1984, Archives of internal medicine.

Outpatient Geriatric Evaluation

Mark E. Williams, 1987, Clinics in geriatric medicine.

Principles of separation: indications and therapeutic targets for plasma exchange.

Mark E. Williams, R. Balogun, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Wa vefront sets of extensions of solutions to diffractive boundary problems.

Mark E. Williams, 1983 .

The Timed Manual Performance Test as a Predictor of Hospitalization and Death in a Community‐Based Elderly Population

Mark E. Williams, M. Gerrity, S. Gaylord, 1994, Journal of the American Geriatrics Society.

A Brief History of the Development of Geriatric Medicine

Mark E. Williams, S. Gaylord, 1994, Journal of the American Geriatrics Society.

Catecholamine modulation of rapid potassium shifts during exercise.

Mark E. Williams, F. Epstein, L. Landsberg, 1985, The New England journal of medicine.

Epstein-Barr virus-induced infectious mononucleosis complicated by acute renal failure: case report and review.

Mark E. Williams, S. Hammer, M. Williams, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.